Clinical Trial Update: Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes testing additional drug treatments after CAR T-cell therapy in patients with relapsed or refractory diffuse large B-ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Grade 3b Follicular Lymphoma
• Mediastinal Large B-cell Lymphoma
• Transformed Follicular Lymphoma
• Transformed Marginal Zone Lymphoma

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma | Phase 2 | Status: RECRUITING